Risky Stem-Cell Treatments Come Under F.D.A. Scrutiny — Again

Wednesday, April 3, 2019 - 10:20 in Health & Medicine

Warning that unapproved stem-cell treatments put patients at risk, the F.D.A. is notifying clinics and manufacturers that flout its rules.

Read the whole article on NY Times Science

More from NY Times Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net